Company DescriptionAstute Medical’s mission is to identify and validate protein biomarkers of severe acute disease.Our focus is community and hospital acquired acute conditions that require rapid diagnosis and risk assessment. Our emphasis is on patients who present to the emergency department with acute symptoms and hospitalized patients who are at risk for an acute event.

Proceeds PurposesThe Company intends to use the proceeds to begin commercializing its first product, as well as to advance and expand its research, development and validation of biomarker-based laboratory tests.